PILLAR NASAL, DORSAL COLUMELLA AND NASAL DORSUM IMPLANTS

K992242 · Pillar Surgical, Inc. · FZE · Nov 22, 1999 · General, Plastic Surgery

Device Facts

• Record ID: K992242
• Device Name: PILLAR NASAL, DORSAL COLUMELLA AND NASAL DORSUM IMPLANTS
• Applicant: Pillar Surgical, Inc.
• Product Code: FZE · General, Plastic Surgery
• Decision Date: Nov 22, 1999
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 878.3680
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The intended use of the Pillar Nasal Implant is to augment or reconstruct facial nasal deformities caused by facial trauma or congenital defects.

Device Story

Pillar Nasal Implant is a silicone-based implant used for surgical augmentation or reconstruction of nasal deformities. The device is implanted by a surgeon using standard surgical methods. It serves as a structural filler to correct nasal eminence deficiencies resulting from trauma, congenital defects, or disease. The implant is manufactured from liquid silicone elastomer, providing a firm, clear-to-opaque structure with specific durometer ranges (Shore A 5-30) to match anatomical requirements. By providing a stable, biocompatible scaffold, the implant restores nasal contour and aesthetics, benefiting patients requiring reconstructive facial surgery.

Clinical Evidence

Bench testing only. No clinical data provided.

Technological Characteristics

Material: Nusil MED 4211 unrestricted silicone fluid. Physical properties: Shore A durometer 5-30; tensile strength ~700 psi; elongation >400%. Form factor: Implantable nasal device. Sterilization: Not specified (instructions provided in package insert).

Indications for Use

Indicated for augmentation or reconstruction of nasal eminence deficiencies, whether congenital or acquired by trauma or disease.

Regulatory Classification

Identification

A nose prosthesis is a silicone rubber solid device intended to be implanted to augment or reconstruct the nasal dorsum.

Predicate Devices

• Silimed, Inc. Elifal nasal (K992242)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the date November 22, 1999, written in a simple, sans-serif font. Below the date, the words "PILLAR SURGICAL" are printed in a larger, bolder font. The word "PILLAR" is underlined, and the two words are stacked on top of each other. To the left of the text is a dark, vertical graphic.

K992242

## Enclosure F

## 510(k) Summary

Substantial Equivalence

The Pillar Nasal Implant is substantially equivalent to the Silimed. Inc Elifal nasal amarketed by Silimed, LLC. The Pillar Nasal Implant is made from identical liquid elastomer materials and manufacturing processes as the predicate device.

Intended Use

The intended use of the Pillar Nasal Implant is to augment or reconstruct facial nasal deformities caused by facial trauma or congenital defects. The Pillar Nasal Implant is implanted using the same accepted surgical methods of the predicate device.

Labeling

The labeling for this device will comprise a label for the inner package and a label for the outer box. Catalog numbers and sizes will package and a ruaged on the labels. A "Package Insert" will contain instructions for sterilization and indications for use. Product promotional material will depict size, shape and material firmness of the implant.

Physical and Chemical Properties

The physical properties of this device are the same as the predicate device in that equivalent materials will be used in manufacturing. The raw materials are Nusil's MED 4211 unrestricted silicone fluid from Nusil Technologies, Inc. The durometers or hardness (shore A) of each implant will range from 5 to 30. The appearance is described as clear to opaque. Tensile strength averages 700 psi and the percent of elongation is over 400 percent. Raw material are certified and tested to comply with the requirements of the manufacturer. For more information, see FDA master-file MAF 612.

{1}------------------------------------------------

Image /page/1/Picture/1 description: The image is a black and white logo for the Department of Health & Human Services - USA. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" written around it. Inside the circle is a stylized symbol that resembles three abstract human profiles facing to the right, stacked on top of each other.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

NOV 22 1999

Mr. Rob Fritzenkotter Pillar Surgical P.O. Box 8141 La Jolla, California 92038

K992242 Re: Trade Name: Nasal, Dorsal Columella, and Nasal Dorsum Implant Regulatory Class: II Product Code: FZE Dated: November 4, 1999 Received: November 5, 1999

## Dear Mr. Fritzenkotter:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

{2}------------------------------------------------

## Page 2 - Mr. Rob Fritzenkotter

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number [phone] or [phone] or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

Neil R.P. Ogden for

James E. Dillard III Acting Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

510(k) NUMBER (IF KNOWN):

DEVICE NAME:

INDICATIONS FOR USE:

Each Pillar Nasal Implant is indicated for the augmentation or reconstruction of nasal eminence deficiencies, whether congenital or acquired by trauma or disease.

NRO for

(Division Sign-Off)
Division of General Restorative Devices K992242
510(k) Number

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED.)

942242

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

OR

Over-The-Counter-Use (Optional Format 1